Exor N.V.
EXXRF | OTC
$81.25
-$1.24 (-1.50%)
At close: Nov 5, 2026, 3:38 PM ET
$81.85
+$0.60 (+0.74%)
Pre-market:
Nov 5, 2026, 11:15 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.04B | 1.9B | 45.41B | 41.84B | 33.62B | 26.79B |
Cost of Revenue | 20M | 14M | 33.43B | 32.34B | 25.98B | 21.94B |
Gross Profit | 1.02B | 1.89B | 11.97B | 9.51B | 7.64B | 4.86B |
Operating Income | -4.57B | 15.34B | 5.98B | 4.11B | 3.14B | -376M |
Interest Income | 58M | 45M | 374M | n/a | n/a | n/a |
Pretax Income | -4.67B | 14.76B | 7.87B | 5.9B | 4.65B | -214M |
Net Income | -3.79B | 14.67B | 4.19B | 4.23B | 1.72B | -30M |
Selling & General & Admin | 60M | 58M | 3.52B | 3.31B | 2.67B | 2.26B |
Research & Development | n/a | n/a | 2.47B | 2.09B | 1.82B | 2.97B |
Other Expenses | 5.53B | n/a | n/a | n/a | 259M | n/a |
Operating Expenses | 5.59B | 58M | 5.99B | 5.4B | 4.76B | 5.23B |
Interest Expense | 100M | 113M | 1.02B | 620M | 169M | 390M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.61B | 58M | 39.45B | 37.74B | 30.48B | 27.17B |
Income Tax Expense | 98M | 91M | 1.1B | 1.06B | 1.3B | 16M |
Shares Outstanding (Basic) | 207.63M | 220.98M | 227.65M | 227.87M | 231.71M | 231.01M |
Shares Outstanding (Diluted) | 207.63M | 220.98M | 227.65M | 233.26M | 231.71M | 231.01M |
EPS (Basic) | -18.27 | 68.27 | 18.38 | 1.78 | 2.43 | -0.62 |
EPS (Diluted) | -18.27 | 67 | 18.42 | 18.10 | 2.43 | -0.62 |
EBITDA | -4.57B | 29.45B | 8.03B | 5.96B | 3.19B | 20.89M |
EBIT | -4.57B | 27.4B | 2.59B | 4.11B | 1.47B | 20.66M |
Depreciation & Amortization | n/a | 2.05B | 2.05B | 1.85B | 1.73B | 226K |
Add to Watchlist
Select watchlists to add or remove EXXRF